“Top Performance” Varispenser 2 and Varispenser 2x –The new Uncompromising Solution for the most Demanding dispensing Applications

New! Uncompromising from the bottom to the top – Eppendorf Varispenser® 2 and Varispenser® 2x Hamburg, August 2017 Bottletop dispensers are needed in any lab where aggressive solutions like lyes, acids, bases or solvents are dispensed from large supply bottles. Bottletop dispensers need to be universally applicable and of uncompromising quality. As a specialist for... Read more

For Immediate Release- Greiner Bio-One Encourages Student Retention Through Donations to the SEA Phages Program

Greiner Bio-One North America, Inc. is proud to announce an agreement to donate bioscience products to the SEA-PHAGES program at University of the Sciences. The SEA-PHAGES program or Science Education Alliance-Phage Hunters Advancing Genomics and Evolutionary Science, is a two semester undergraduate program that aims to increase undergraduate interest and retention in the sciences by... Read more

The VWR Foundation Approves Over $140,000 in Grants

RADNOR, Pa., Aug. 9, 2017 /PRNewswire/ — The VWR Foundation, a charitable organization dedicated to giving back to the science community, distributed 20 grants totaling over $140,000 during its Board Meeting in July. During the meeting, Board Members reviewed a record number of grant applications including many organizations new to the Foundation. Among the grant recipients... Read more

Shimadzu Global Innovation Summit 2017 – IMAGINE, INNOVATE & INSPIRE –

Many of the KOL work closely with Shimadzu Innovation Centers and Application Development & Support Center located across the world including, China, Germany, Singapore and the United States. These institutes were founded in response to numerous collaborations and are staffed by Shimadzu scientists and equipped with Shimadzu instrumentations. This has enabled Shimadzu to stay in... Read more

CHMP recommends EU approval of Roche’s Gazyvaro for people with previously untreated advanced follicular lymphoma

Basel, 21 July 2017 CHMP recommends EU approval of Roche’s Gazyvaro for people with previously untreated advanced follicular lymphoma Pivotal GALLIUM study demonstrated that Gazyvaro-based treatment helped people with previously untreated follicular lymphoma live significantly longer without disease progression compared to MabThera-based treatment Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the EU Committee... Read more